Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies
Prior to the amendments, restricted drugs such as psilocybin and MDMA were not accessible through SAP.
- Prior to the amendments, restricted drugs such as psilocybin and MDMA were not accessible through SAP.
- Since the opening of our first Field Trip Health Center in Toronto in 2020, weve helped people around the world experience relief from suffering and find joy, wonder and fulfilment through our psychedelic therapies, said Hannan Fleiman, President of Field Trip.
- About Field Trip Health Ltd.
Field Trip is a global leader in the development and delivery of psychedelic therapies. - Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect.